CYP1A1 and chronic myelogenous leukemia, BCR-ABL1 positive: Association of The Common CYP1A1*2C Variant
(Ile462Val Polymorphism) with Chronic MyeloidLeukemia (CML) in Patients UndergoingImatinib Therapy